Drug profile

The FDA adverse-event record for Coconut Oil

41 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Coconut Oil. See the species affected, top reactions, and outcomes below.

41
adverse-event reports
4.9%
death-coded share
Dog
most-reported species
10
Lethargy (see also Central nervous system depression in 'Neurological') - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
41
Total Reports
2
Deaths Reported
4.9%
Death Rate

Active Ingredients

Coconut Oil

Administration Routes

OralTopicalUnknownCutaneous

Species Affected

Dog 37
Cat 4

Most Affected Breeds

Crossbred Canine/dog 4
Spitz - German Pomeranian 4
Doberman Pinscher 3
Pit Bull 3
Domestic Shorthair 3
Shepherd Dog - Australian 2
Retriever - Golden 2
Shepherd Dog - German 2
Sheepdog - Shetland 1
Poodle - Standard 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 10
Vomiting 7
Vocalisation 5
Pruritus 5
Behavioural disorder NOS 5
Panting 4
Emesis 4
Anorexia 4
Lack of efficacy (ectoparasite) - flea 4
Diarrhoea 3
Alopecia local 3
Seizure NOS 3

Outcome Breakdown

Outcome Unknown
18 (43.9%)
Recovered/Normal
12 (29.3%)
Ongoing
7 (17.1%)
Recovered with Sequela
2 (4.9%)
Died
1 (2.4%)
Euthanized
1 (2.4%)

Coconut Oil Adverse Event Insights

41 reports name Coconut Oil; 2 recorded a death outcome (4.9% of reported events, not a population-level mortality rate). Active ingredient: Coconut Oil. Administration routes: Oral, Topical, Unknown, Cutaneous.

By species: Dog (37 reports), Cat (4 reports). By breed: Crossbred Canine/dog (4), Spitz - German Pomeranian (4), Doberman Pinscher (3).

Leading clinical signs: Lethargy (see also Central nervous system depression in 'Neurological') (10), Vomiting (7), Vocalisation (5), Pruritus (5). Outcome, 41 coded reports: Outcome Unknown leads at 43.9%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.